Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 September 2020
Class of 2020

Dear Graduand

VIRTUAL GRADUATION CEREMONIES, 6-9 OCTOBER 2020

The COVID-19 pandemic has caused immense disruption in many aspects of our lives, both in South Africa and abroad. Higher education institutions throughout the world were not exempt from the effects of the deadly virus. In South Africa in particular, most institutions were forced to suspend academic programmes and quickly found themselves transitioning academic programmes from the classroom to online learning platforms. 

We also postponed graduation ceremonies in the hope that the situation would improve in time. Unfortunately, the situation has not improved, and as COVID-19 continues to present uncertainties and public health concerns, we have made the decision not to present our face-to-face graduation ceremonies on the Bloemfontein and Qwaqwa Campuses.  

On the other hand, the pandemic has propelled innovation and creativity; we are delighted at the possibilities offered by technology to allow us to honour and preserve traditions that define the higher education experience. Your graduation and the conferring of your degree should be an unforgettable moment in your life. Therefore, we are making every effort to ensure that even during these unusual times, you are celebrated.  You have committed countless hours of dedicated work to earn your degree, and we would like to support you in celebrating this momentous occasion. 
Therefore, as an alternative, we are hosting virtual graduation ceremonies scheduled to be broadcasted from 6 to 9 October 2020 at 10:00 daily: 

• 6 October 2020: Bloemfontein Campus (April 2020, all ceremonies)
• 7 October 2020: Qwaqwa Campus (May 2020, all ceremonies)
• 8 October 2020: Bloemfontein Campus (June 2020 undergraduate and honours ceremonies)
• 9 October 2020: Bloemfontein Campus (June 2020 master’s and PhD qualifications)

The institution is aware of and sensitive to the increased need to have your qualification certificates.  We therefore wish to inform our graduates that certificates will be available and released immediately after the conferral ceremonies. It is our utmost priority to ensure your health and safety. As a result, certificates will be available and released via courier services at no cost to you and within convenient measures in adherence to the COVID-19 prescriptions. Communication regarding the issuing of the certificates will follow in due course.
 
Your disappointment at not having a face-to-face ceremony is understandable – however, it is extremely important that we do what is in the best interest of our students, staff, and community. 

Congratulations to all our graduates and may you have continued success in all your endeavours! 

We look forward to honouring you at the virtual graduation ceremony. 


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept